AstraZeneca files US FDA application for HUTCHMED lung cancer drug combination

HUTCHMED (China) HKEX:13 said on Tuesday Anglo-Swedish drugmaker AstraZeneca LSE:AZN had filed an application with the US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination in patients with advanced lung cancer.ORPATHYS is being jointly developed by AstraZeneca and HUTCH…